News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Eyes Local Prospects



11/29/2016 7:40:11 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Defying sporadic withdrawals of foreign companies and a perceived economic slowdown, AstraZeneca is adopting a "lean in" strategy in China with more locally developed drugs and wider outreach, Pascal Soriot, CEO of the Anglo-Swedish pharmaceuticals giant, told China Daily.

Tagrisso, the company's latest drug for treating lung cancer with the EFGR-mutation, is expected to receive approval in China soon. The drug has been under fast-track review, because nearly half of Chinese lung cancer patients have this mutation.

Read at China Daily


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES